Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)
South Korea · Delayed Price · Currency is KRW 5,080.00
-50.00 (-0.97%)
At close: Sep 11, 2026
Kyung Dong Pharmaceutical Market Cap
Kyung Dong Pharmaceutical has a market cap or net worth of 148.84 billion as of September 11, 2026. Its market cap has decreased by -7.92% in one year.
Market Cap
148.84B
Enterprise Value
147.08B
Revenue
201.12B
Ranking
n/a
PE Ratio
7.84
Stock Price
5,080.00
ChartMarket Cap Chart
Since January 29, 2001, Kyung Dong Pharmaceutical's market cap has increased from 44.35B to 148.84B, an increase of 235.60%. That is a compound annual growth rate of 4.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 148.84B | -5.40% |
| Dec 30, 2025 | 157.34B | -4.73% |
| Dec 30, 2024 | 165.15B | -7.92% |
| Dec 28, 2023 | 179.35B | -16.01% |
| Dec 29, 2022 | 213.54B | -31.89% |
| Dec 30, 2021 | 313.54B | 1.02% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DAE HWA Pharmaceutical | 198.23B |
| NOVAREX | 176.32B |
| Vivozon Pharmaceutical | 174.48B |
| GC WellBeing | 170.58B |
| CellBion | 161.32B |
| Cosmax Nbt | 153.96B |
| PHARMARESEARCH BIO | 126.68B |
| HYUNDAI BIOLAND | 119.40B |